TrialGynecologic oncology2011

Cadherins, catenins and cell cycle regulators: impact on survival in a Gynecologic Oncology Group phase II endometrial cancer trial.

Meenakshi Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.